MR Image Guided Gynecologic Brachytherapy
MR Image Guided Gynecologic Brachytherapy
批准号:
9308474
负责人:
Akila Viswanathan
金额:
$5.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-06 至 2017-08-31
中文摘要
描述(由申请人提供):妇科癌症局限于盆腔的患者可采用放射治疗。近距离放射治疗的使用,即在外部射束辐射后将放射性种子直接放置到肿瘤中心,允许肿瘤的剂量递增,导致肿瘤的成功消退和根除。然而,在肿瘤附近,包括小肠、乙状结肠、直肠和膀胱在内的重要正常组织结构可能位于可以接受高剂量辐射的区域。在美国的大多数中心,简单的成像(X射线或CT)与剂量规定到一个单一的点是标准的护理。正常组织不是由其实际尺寸定义的,而是由近似其位置的点定义的。为了成功地确定肿瘤的位置及其与正常组织结构的关系,以便最大限度地减少对它们的剂量,有必要在近距离放射治疗施源器放置期间对骨盆进行成像。MRI比其他成像方式更精确地描绘骨盆中的肿瘤和OAR。在这项临床试验中,除了DWI MRI之外,还将研究3T T2加权MRI成像的实用性,以及图像与活检证实的癌症存在的相关性。
英文摘要
DESCRIPTION (provided by applicant): Patients with gynecologic cancers localized to the pelvis may be curatively treated with radiation. The use of brachytherapy, the placement of radioactive seeds directly into the center of the tumor, after external beam radiation, permits dose escalation to the tumor, resulting in successful regression and eradication of the tumor. However, adjacent to the tumor, critical normal tissue structures including the small bowel, sigmoid, rectum, and bladder may rest in regions that can receive high doses of radiation. In most centers in the U.S., simple imaging (X-ray or CT) with doses prescribed to a single point are the standard of care. Normal tissues are not defined by their actual dimensions, rather by points that approximate their location. In order to successfully determine the location of the tumor and its relationship to the normal tissues structures in order to minimize the dose to them, it is necessary to image the pelvis during brachytherapy applicator placement. MRI delineate tumor and OAR in the pelvis with much more precision than other imaging modalities. In this clinical trial, the utility of 3T T2- weighted MRI imaging, in addition to DWI MRI, and how the images correlate with biopsy-confirmed presence of cancer will be studied.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
A fast multitarget inverse treatment planning strategy optimizing dosimetric measures for high‐dose‐rate (HDR) brachytherapy
一种快速多目标逆向治疗计划策略,优化高剂量率 (HDR) 近距离放射治疗的剂量测量
DOI:
10.1002/mp.12410
发表时间:
2017
期刊:
Medical Physics
影响因子:
3.8
作者:
[Guthier, Damato, Viswanathan, Hesser, Cormack]
通讯作者:
Cormack
Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement
-
批准号:10350630
-
项目类别:
-
资助金额:$51.62万
-
财政年份:2020
-
负责人:Akila Viswanathan
-
依托单位:
Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement
-
批准号:9885051
-
项目类别:
-
资助金额:$55.67万
-
财政年份:2020
-
负责人:Akila Viswanathan
-
依托单位:
Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement
-
批准号:10642660
-
项目类别:
-
资助金额:$51.41万
-
财政年份:2020
-
负责人:Akila Viswanathan
-
依托单位:
Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement
-
批准号:10116323
-
项目类别:
-
资助金额:$52.75万
-
财政年份:2020
-
负责人:Akila Viswanathan
-
依托单位:
MR Image Guided Gynecologic Brachytherapy
-
批准号:8443663
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:Akila Viswanathan
-
依托单位:
MR Image Guided Gynecologic Brachytherapy
-
批准号:8731185
-
项目类别:
-
资助金额:$13.79万
-
财政年份:2013
-
负责人:Akila Viswanathan
-
依托单位:
Inflamation and the Risk of Endometrial Cancer
-
批准号:7473124
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2006
-
负责人:Akila Viswanathan
-
依托单位:
Inflamation and the Risk of Endometrial Cancer
-
批准号:7015894
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2006
-
负责人:Akila Viswanathan
-
依托单位:
Inflamation and the Risk of Endometrial Cancer
-
批准号:7637878
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2006
-
负责人:Akila Viswanathan
-
依托单位:
Inflamation and the Risk of Endometrial Cancer
-
批准号:7877739
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2006
-
负责人:Akila Viswanathan
-
依托单位:
Inflamation and the Risk of Endometrial Cancer
-
批准号:7269379
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2006
-
负责人:Akila Viswanathan
-
依托单位:
国内基金
海外基金
基于CE-3及IMAGE卫星地球等离子体层EUV探测数据的反演研究
-
批准号:41904148
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2019
-
负责人:黄娅
-
依托单位:
Raw-Image微小物体高精度位姿测量法
-
批准号:61105029
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:宋薇
-
依托单位: